Next Article in Journal
Clinical Course, Outcomes, and Risk Factors of Myocarditis and Pericarditis Following Administration of mRNA-1273 Vaccination: A Protocol for a Federated Real-World Evidence Vaccine Safety Study Using Data from Five European Data Sources
Next Article in Special Issue
Optimization of YF17D-Vectored Zika Vaccine Production by Employing Small-Molecule Viral Sensitizers to Enhance Yields
Previous Article in Journal
Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
Previous Article in Special Issue
From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity
 
 
Review

Article Versions Notes

Vaccines 2025, 13(7), 754; https://doi.org/10.3390/vaccines13070754
Action Date Notes Link
article pdf uploaded. 15 July 2025 15:41 CEST Version of Record https://www.mdpi.com/2076-393X/13/7/754/pdf-vor
article xml file uploaded 16 July 2025 09:11 CEST Original file -
article xml uploaded. 16 July 2025 09:11 CEST Update https://www.mdpi.com/2076-393X/13/7/754/xml
article pdf uploaded. 16 July 2025 09:11 CEST Updated version of record https://www.mdpi.com/2076-393X/13/7/754/pdf
article html file updated 16 July 2025 09:12 CEST Original file https://www.mdpi.com/2076-393X/13/7/754/html
Back to TopTop